City
Latest
SHORTS
National
International
Cricket
Maharashtra
Entertainment
LT Premium
Web Stories
Chhatrapati Sambhajinagar
Trending Topics :
USA-Israel Attack
Assembly Elections 2026
IPL 2026
Stock Market News
Maharashtra News
Mumbai Local
Marathi
|
Hindi
x
Epaper
FOLLOW US :
Home
City
City
Ahmednagar
Akola
Amravati
Aurangabad
Beed
Bhandara
Buldhana
Chandrapur
Dhule
Gadchiroli
Goa
Gondia
Hingoli
Jalana
Jalgaon
Kolhapur
Latur
Malegaon
Nagpur
Nanded
Nandurbar
Nashik
Navi Mumbai
Pandharpur
Parabhani
Pimpri-Chinchwad
Pune
Raigad
Ratnagiri
Sangli
Satara
Sindhudurga
Solapur
Thane
Usmanabad
Vardha
Vasai Virar
Vashim
Yavatmal
Khamgaon
Bhusawal
Palghar
Itanagar
Dispur
Patna
Raipur
Panaji
Gandhinagar
Shimla
Ranchi
Bengaluru
Thiruvananthapuram
Bhopal
Mumbai
Imphal
Shillong
Aizawl
Kohima
Bhubaneswar
Jaipur
Gangtok
Chennai
Hyderabad
Agartala
Lucknow
Dehradun
Gairsain
Kolkata
Port Blair
Chandigarh
Daman
New Delhi
Srinagar
Jammu
Kavaratti
Pondicherry
Leh
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
All
News
Photos
Bharat Biotech International
FOLLOW
Bharat-biotech, Latest Marathi News
National :
Bharat Biotech applies for market authorisation from DCGI for five arms intranasal heterologous booster
Health :
Bharat Biotech’s nasal Covid-19 vaccine cleared for use in India
Health :
India's first intranasal vaccine for Covid gets DCGI approval
Health :
Bharat Biotech completes trials for intranasal Covid vax - BBV154
Health :
Bharat Biotech's intranasal Covid vaccine proven safe in clinical trials
International :
Japan approves COVAXIN booster dose for travellers: Bharat Biotech
National :
Covaxin booster dose increases immune response by 40 times, gives long-term immunity against COVID-19: Bharat Biotech
Health :
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Health :
Bharat Biotech seeks nod for Covaxin booster trials for 2-18 age group
National :
Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials in 2-18 age group
Previous Page
Next Page